|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 50, 938-944, May 2009 The thyromimetic T-0681 protects from atherosclerosis
* Department of Internal Medicine, Innsbruck Medical University, Innsbruck, Austria This work was supported by the Hans and Blanca Moser Stiftung (No. 61-1994/95 to I.T.), by the Medizinische Forschungsfoerderung Innsbruck (No. 4316 to I.T.), by the Jubiläumsfond der Oesterreichischen Nationalbank (No. 12156 to I.T. and A.R.), and by the Fonds zur Foerderung der wissenschaftlichen Forschung (P19999-B05 to A.R.). Published, JLR Papers in Press, December 22, 2008.
1 To whom correspondence should be addressed. e-mail: ivan.tancevski{at}i-med.ac.at This report describes studies in hyperlipidemic New Zealand White (NZW) rabbits investigating the impact of the liver-selective thyromimetic T-0681 on lipoprotein metabolism and the development of atherosclerosis. Prolonged treatment with T-0681 increased the hepatic expression of both LDL receptor and scavenger receptor class B, type I without affecting cholesteryl ester transfer protein activity. Upregulation of hepatic lipoprotein receptors was accompanied by a marked decrease of apolipoprotein B-containing lipoproteins, reflected by a 60% reduction of plasma cholesterol and a >70% reduction of plasma triglyceride levels. Most importantly, T-0681 reduced the development of atherosclerosis by 80% in NZW rabbits on high-cholesterol chow. Our data suggest that liver-selective thyromimetics, such as T-0681, may prove to be useful therapeutic agents against the development of atherosclerosis in humans.
Supplementary key words liver-selective thyromimetic low density lipoprotein receptor scavenger receptor class B, type I potential side effects Abbreviations: ABCA1, adenosine 5'-triphosphate-binding cassette transporter 1; AcLDL, acetylated low density lipoprotein; ALT, alanine-aminotransferase; apoB, apolipoprotein B; AST, aspartate-aminotransferase; CETP, cholesteryl ester transfer protein; CYP7A1, cholesterol 7
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||